Dr. Ashish Duggal chairs this evidence-driven keynote delivered by Dr. Debashish Chowdhury. The session delves into the significant personal and societal burden of migraine while evaluating the growing body of evidence supporting next-generation acute therapies, with a focus on improving patient outcomes.

Migraine Burden and the Evidence for Next-Generation Acute Therapies

RCP Migraine 2.0: Review of Current Practice in Migraine is a focused one-day virtual academic initiative dedicated to advancing contemporary migraine care through evidence-based discussions and real-world clinical insights. Scheduled for September 11th, 2026, this high-impact program brings together leading experts to address critical gaps in acute migraine management and explore emerging therapeutic paradigms.

Under the scientific leadership of Dr. Debashish Chowdhury, the conference will center on the evolving role of novel therapies, with a special focus on CGRP antagonists such as rimegepant, and their application in routine clinical practice.

The agenda is designed to deliver clinically relevant, practice-oriented insights, covering:
- Limitations of Conventional Therapies – Understanding medication overuse, triptan resistance, and unmet patient needs
- Expanding Acute Treatment Options – Managing the triptan-insufficient response with newer agents like gepants
- Limitations of Conventional Therapies – Understanding medication overuse, triptan resistance, and unmet patient needs - Expanding Acute Treatment Options – Managing the triptan-insufficient response with newer agents like gepants
- Burden of Migraine & Emerging Evidence – Clinical and patient-centric rationale for next-generation therapies - CGRP antagonists in Prophylaxis – Addressing breakthrough attacks and redefining preventive strategies
- Complex Case Discussions – Real-world approaches in migraine prophylaxis with newer agents and status migrainosus with evolving emergency care protocols

Through expert-led keynotes and case-based discussions, RCP Migraine 2.0 aims to bridge the gap between clinical evidence and real-world practice, enabling clinicians to make informed, patient-centric treatment decisions.

Join us for an engaging academic experience and stay at the forefront of innovation in migraine management.

RCP Migraine 2026

RCP Migraine brought the latest global evidence. 'Meet the Expert' now takes it a step further by translating those learnings into clinical practice through real-world case discussions, practical insights, and interactive Q&A. Episode 1 goes live on 25th September at 8:30 PM - you may register below. Also, if you have an interesting or challenging migraine case, share it with us. If shortlisted you will have an opportunity to present your case during the session and engage directly with experts.

Meet The Expert : Episode 1

RCP Migraine: Review in Current Practice in Migraine is a two-day live virtual conference dedicated to advancing migraine care. Join leading experts as they explore the latest scientific advancements, clinical data, and real-world applications in migraine management. Stay at the forefront of migraine treatment with cutting-edge insights and evidence-based strategies.

Key Topics

🔷 Migraine Subtypes & Prevalence – Global and regional insights shaping clinical decisions

🔷 Current Treatment Paradigms – Addressing gaps in therapy for better patient outcomes

🔷 CGRP Antagonists & Beyond – The paradigm shift in acute and preventive strategies

🔷 Cutting-Edge Therapies – From Gepants to neuromodulation—what’s next?

🔷 Preventive Migraine Management – Evidence-based updates and guideline-driven approaches

🔷 Real-World Case Insights – Experience sharing on Rimegepant and its clinical implementation

This conference will provide practical takeaways to refine your approach to migraine care. Stay ahead and transform your migraine practice. Register now!

RCP Migraine Day 2

Chaired by Dr. Ashish Duggal, this session features Dr. Debashish Chowdhury exploring the current therapeutic landscape in migraine care. From conventional approaches to emerging treatments, the discussion dives deep into real-world usage patterns, unmet patient needs, and where the gaps in migraine therapy still lie - setting the tone for innovation and change.

Current Treatment Paradigms and Gaps in Therapy: What’s being used vs. what’s missing?

RCP Migraine Day 1

Professor of Neurology, ABVIMS and Dr Ram Manohar Lohia Hospital, New Delhi

Dr. Ashish Duggal

6

5k

212k

4.7

Sessions Taken

636

4.8

552

4.8

982

4.6

1.3k

4.8

2.2k

4.7

1.6k

4.7